SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-19-000124
Filing Date
2019-12-19
Accepted
2019-12-19 08:33:15
Documents
3
Period of Report
2019-12-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201912198xkdoc.htm 8-K 28223
2 PRESS RELEASE pdli-201912198xkex991.htm EX-99.1 15764
3 pdllogo2a07.jpg GRAPHIC 123123
  Complete submission text file 0000882104-19-000124.txt   214736
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 191294199
SIC: 2836 Biological Products, (No Diagnostic Substances)